Back Stocks profile

Stock analysis tool for investors

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE:524348

₹526.70 1.10 (0.21%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

525.00

Today’s High

532.50

52W low

431.00

52W High

625.00

Open Price

526.90

Prev. Close

492.0500

Volume

86293.00

Value

45450523.10

Fundamentals

Market Cap

4842.20

Price to Earnings

30.90

Price to Book Value

3.80

Dividend Yield

0.20

PE to Growth

-2.50

Op Revenue TTM

2422.81

Net Profit TTM

156.81

Cash From Operating Activity

358.92

Return on Equity %

13.38

EMA & SMA

Bullish Moving Averages

10

Bearish Moving Averages

6

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

26 Jul, 2024

44.7

Week

42.4

Month

42.6

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

528.07

PIVOT

First Resistance

531.13

Second Resistance

535.57

Third Resistance

538.63

First Support

523.63

Second Support

520.57

Third Support

516.13

Relative Strength Index

51.21

Money Flow Index

41.86

MACD

2.93

MACD Signal

5.22

Average True Range

15.75

Average Directional Index

14.51

Rate of Change (21)

2.69

Rate of Change (125)

-1.63

Commodity Channel Index

-32.4

Williams %R

-62.8

BETA

1 Month

-0.08

3 Month

0.58

1 Year

0.72

3 Year

0.4

PRICE CHANGE ANALYSIS

2.64%

1 Week

Low

High

505.05

536.25

2.69%

1 Month

Low

High

501.4

563.2

4.47%

3 Months

Low

High

451.05

563.2

4.39%

6 Months

Low

High

431.05

568

-9.42%

1 Year

Low

High

431.05

625

Bigul
26 Jul 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release on Q1FY25 Business and Financial Performance
Bigul
26 Jul 2024

AARTI DRUGS LTD. - 524348 - Financial Results For The Quarter Ended June 30, 2024

Financial Results for the quarter ended June 30, 2024
Bigul
19 Jul 2024

AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Intimation Of Board Meeting

AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 ,inter alia, to consider and approve This is to inform you that next Board Meeting of the Board of Directors of the Company is scheduled to be held on Friday, July 26, 2024 to consider, approve and take on record Audited Financial Results for the Quarter ended June 30, 2024.
Bigul
17 Jul 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances

Closure of manufacturing activity of particular product at T-150 Unit pursuant to Voluntary Closure Directions of MPCB
Bigul
10 Jul 2024

AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
See all News

FAQs

The latest market price of Aarti Drugs Ltd. on NSE was Rs. 526.70 as of today.

The opening share price of Aarti Drugs Ltd. was Rs. 526.90 as of today.

The 52-week high share price of Aarti Drugs Ltd. was Rs. 625.00.

The 52 week low share price of Aarti Drugs Ltd. was Rs. 431.00.

Please find Corporate actions section for more details.

The PE ratio of Aarti Drugs Ltd. is -2.50. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aarti Drugs Ltd. was on 2024-02-06 for Rs. 1 per share. According to today’s share price, the dividend yield of Aarti Drugs Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Aarti Drugs Ltd. was as of 2020-09-30. The bonus ratio declared in this issue was 3:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aarti Drugs Ltd..

Close

Let's Open Free Demat Account